
News & Articles
Home / About Barrow Neurological Institute / Archives for Andrew Wachtel
Author: Andrew Wachtel
Ivy Brain Tumor Center Expands Global Phase 3 Gliofocus Study
- As Seen In
- Byline: Andrew Wachtel
- January 15, 2025
The Ivy Brain Tumor Center at Barrow Neurological Institute has announced the expansion of the Gliofocus Study, activating two new sites in Europe and two additional locations in...
Could Reducing Environmental Toxins Help Mitigate the Risk for Parkinson’s Disease?
- As Seen In
- Byline: Andrew Wachtel
- November 18, 2024
A new study found that exposure to air pollution not only increased the risk of developing Parkinson's disease, but also that differences in exposure to environmental toxins were...
Ivy Brain Tumor Center Announces Phase 0/2 Clinical Readout of Niraparib
- As Seen In
- Byline: Andrew Wachtel
- May 23, 2024
Indicates significant improvement in overall survival of newly diagnosed glioblastoma patients.
Ivy Brain Tumor Center Awarded U.S. Department of Defense Grant
- As Seen In
- Byline: Andrew Wachtel
- March 28, 2024
The Ivy Brain Tumor Center at Barrow Neurological Institute received a $1.48 million, three-year U.S. Department of Defense (DoD) Impact Award to advance the development of MnP3.
Arizona Mining Project Sparks Concerns for Air and Water
- As Seen In
- Byline: Andrew Wachtel
- March 15, 2024
A study led by Dr. Brad Racette, a leading researcher on clinical manganese exposure, suggests manganese can cause adverse health effects at exponentially lower levels